Long-term clinical outcome after percutaneous transluminal coronary angioplasty with provisional stenting

Michail I Papafaklis1, Katerina K Naka, Lampros Sioros

  • 1Michaelideion Cardiac Center, Ioannina, Greece.

Insights

Long-term follow-up of coronary angioplasty with provisional stenting shows 78% survival at 9 years. Certain patient factors, like age and diabetes, significantly impact outcomes, with nearly half experiencing cardiac events.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Medicine
  • Clinical Outcomes Research

Background:

  • Long-term follow-up studies are crucial in interventional cardiology despite rapid technological advancements.
  • Understanding limitations and guiding future changes in cardiac procedures is essential.

Purpose of the Study:

  • To report the 9-year clinical outcomes of patients undergoing coronary angioplasty with provisional stenting.
  • To identify factors influencing long-term survival and major adverse cardiac events.

Main Methods:

  • Retrospective analysis of 409 consecutive patients treated between 1995-1999.
  • Data collection included baseline characteristics, survival, cardiac events, and symptoms via medical records and telephone contact.
  • Statistical analysis to determine survival rates and predictive factors.

Main Results:

  • 98.5% follow-up achieved in 403 patients.
  • Cumulative 9-year survival rate was 78%; survival free from major adverse cardiac events was 55%.
  • Independent predictors of survival included age >65, diabetes, hypertension, multivessel disease, and ejection fraction <50%.

Conclusions:

  • Long-term survival after coronary angioplasty with provisional stenting is influenced by specific patient factors.
  • Approximately 45% of patients experienced a subsequent cardiac event within the 9-year follow-up period.
  • Patients with favorable characteristics (younger, non-diabetic, single-vessel disease) had survival rates comparable to the general population.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...